Fusikab B Cream is a topical medication combining Beclometasone (0.025% w/w), a potent corticosteroid, and Fusidic Acid (2% w/w), a bacteriostatic antibiotic, formulated to treat inflammatory skin conditions complicated by bacterial infections. Beclometasone works by reducing inflammation, redness, and itching through its anti-inflammatory and immunosuppressive effects, while Fusidic Acid targets and inhibits the growth of susceptible bacteria, particularly Staphylococcus species, thereby preventing or treating secondary bacterial infections. This dual-action cream is commonly prescribed for conditions such as infected eczema, dermatitis, and other inflammatory dermatoses where bacterial superinfection is present or likely. Fusikab B Cream should be applied in a thin layer to the affected area, usually twice daily, as directed by a healthcare professional. It is important to avoid prolonged use to minimize potential side effects associated with corticosteroids, such as skin thinning or irritation. The cream is intended for external use only and should not be applied to open wounds or mucous membranes. Patients should inform their doctor of any allergies or pre-existing skin conditions before use. Fusikab B Cream offers an effective combination therapy to manage inflammatory skin disorders complicated by bacterial infection, promoting faster healing and symptom relief.